| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | — | −1.8× | — |
| Price / Book | — | 2.1× | — |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | — | −1.6× | — |
| EV / EBITDA | — | −1.2× | — |
| Earnings yield | — | −14.0% | — |
| Free cash flow yield | — | −9.5% | — |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,267.23 | −3.02% | $1.19T | 59.6× | 77.8% | +21.1% |
| $263.79 |
| −1.43% |
| $635.02B |
| 24.0× |
| 32.9% |
| +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.54 | +0.12% | $504.58B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $417.65 | −1.72% | $374.88B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.02 | −1.51% | $357.79B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $149.86 | −4.11% | $270.03B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.96 | −0.93% | $265.14B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $671.31 | −0.77% | $248.22B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $439.92 | −1.65% | $237.83B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.81 | −0.24% | $194.44B | 22.9× | 37.5% | +26.7% |
